The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

 
Web www.patentalert.com

< Alkaline phosphatase to induce weight loss or to reduce weight gain

< Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process

> C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

> Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors

~ 00247